Report cover image

CRISPR Therapeutics AG - Company Profile and SWOT Analysis

Publisher MarketLine
Published Dec 22, 2025
Length 41 Pages
SKU # MTLN20809329

Description

CRISPR Therapeutics AG - Company Profile and SWOT Analysis

Summary

CRISPR Therapeutics AG - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

CRISPR Therapeutics AG (CRISPR Therapeutics) is a biotechnology company focused on developing gene-based medicines for serious human diseases. The company specialises in CRISPR/Cas9 technology to create therapeutics that can disrupt, delete, correct, and insert genes. Its major product is CASGEVY, a CRISPR-based therapy for hemoglobinopathies such as sickle cell disease and transfusion-dependent beta thalassemia. The company's products are primarily used in the healthcare industry, specifically in the treatment and prevention of both rare and common diseases. CRISPR Therapeutics collaborates with Vertex Pharmaceuticals Incorporated to advance its therapeutic programs. The company's products are used in healthcare applications, particularly in treating genetic disorders and developing advanced cellular therapies. CRISPR Therapeutics is headquartered in Zug, Switzerland.

Scope
  • Detailed information on CRISPR Therapeutics AG required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting CRISPR Therapeutics AG in the form of a SWOT analysis
  • An in-depth view of the business model of CRISPR Therapeutics AG including a breakdown and examination of key business segments
  • Intelligence on CRISPR Therapeutics AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about CRISPR Therapeutics AG, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
  • Gain understanding of CRISPR Therapeutics AG and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess CRISPR Therapeutics AG as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on CRISPR Therapeutics AG's business structure, strategy and prospects.

Table of Contents

41 Pages
Company Snapshot
CRISPR Therapeutics AG: Company Overview
CRISPR Therapeutics AG: Overview and Key Facts
CRISPR Therapeutics AG: Overview
CRISPR Therapeutics AG: Key Facts
CRISPR Therapeutics AG: Key Employees
CRISPR Therapeutics AG: Key Employee Biographies
CRISPR Therapeutics AG: Major Products and Services
CRISPR Therapeutics AG: Management Statement
CRISPR Therapeutics AG: Locations and Subsidiaries
CRISPR Therapeutics AG: Key Competitors
CRISPR Therapeutics AG: Company Analysis
CRISPR Therapeutics AG: Business Description
CRISPR Therapeutics AG: SWOT Analysis
CRISPR Therapeutics AG: SWOT Overview
CRISPR Therapeutics AG: Strengths
CRISPR Therapeutics AG: Weaknesses
CRISPR Therapeutics AG: Opportunities
CRISPR Therapeutics AG: Threats
CRISPR Therapeutics AG: Corporate Financial Deals Activity
CRISPR Therapeutics AG: Financial Deals Overview
CRISPR Therapeutics AG: Targets and Partners
CRISPR Therapeutics AG: Top Deals 2021 - 2025YTD*
CRISPR Therapeutics AG: Advisors
CRISPR Therapeutics AG: Top Legal Advisors
CRISPR Therapeutics AG: Top Financial Advisors
CRISPR Therapeutics AG: Corporate Venturing
CRISPR Therapeutics AG: Capital Raising
CRISPR Therapeutics AG: Partnership
CRISPR Therapeutics AG: Recent Developments
CRISPR Therapeutics AG: News and Events Summary
CRISPR Therapeutics AG: Corporate Governance
CRISPR Therapeutics AG: Financial Performance
CRISPR Therapeutics AG: Market Developments
CRISPR Therapeutics AG: Regulatory and Legal Events
CRISPR Therapeutics AG: Research & Development
CRISPR Therapeutics AG: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: CRISPR Therapeutics AG: Key Facts
Table 2: CRISPR Therapeutics AG: Key Employees
Table 3: CRISPR Therapeutics AG: Locations and Subsidiaries
Table 4: CRISPR Therapeutics AG: Key Competitors
Table 5: CRISPR Therapeutics AG: Deal Activity by Deal Type - Volume (TTM*)
Table 6: CRISPR Therapeutics AG: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Table 7: CRISPR Therapeutics AG: Targets and Partners
Table 8: CRISPR Therapeutics AG: Top Deals 2021 - 2025YTD*
Table 9: CRISPR Therapeutics AG: Legal Advisor Ranking by Value (US$m)
Table 10: CRISPR Therapeutics AG: Financial Advisor Ranking by Value (US$m)
Table 11: CRISPR Therapeutics AG: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
Table 12: CRISPR Therapeutics AG: Corporate Venturing by Geography (2021 - YTD*2025)
Table 13: CRISPR Therapeutics AG: Capital Raising Volume and Value Trend (2021 - YTD*2025)
Table 14: CRISPR Therapeutics AG: Capital Raising by Deal Type (2021 - YTD*2025)
Table 15: CRISPR Therapeutics AG: Partnership Volume and Value Trend (2021 - YTD*2025)
Table 16: CRISPR Therapeutics AG: Partnership Trend by Deal Type (2021 - YTD*2025)
Table 17: CRISPR Therapeutics AG: News and Events Summary
Table 18: CRISPR Therapeutics AG: Corporate Governance
Table 19: CRISPR Therapeutics AG: Financial Performance
Table 20: CRISPR Therapeutics AG: Market Developments
Table 21: CRISPR Therapeutics AG: Regulatory and Legal Events
Table 22: CRISPR Therapeutics AG: Research & Development
Table 23: CRISPR Therapeutics AG: Strategy and Operations
List of Figures
Figure 1: CRISPR Therapeutics AG: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: CRISPR Therapeutics AG: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Figure 3: CRISPR Therapeutics AG: Corporate Venturing Volume and Value Trend (2021 - YTD*2025)
Figure 4: CRISPR Therapeutics AG: Corporate Venturing by Geography (2021 - YTD*2025)
Figure 5: CRISPR Therapeutics AG: Capital Raising Volume and Value Trend (2021 - YTD*2025)
Figure 6: CRISPR Therapeutics AG: Capital Raising by Deal Type (2021 - YTD*2025)
Figure 7: CRISPR Therapeutics AG: Partnership Volume and Value Trend (2021 - YTD*2025)
Figure 8: CRISPR Therapeutics AG: Partnership Trend by Deal Type (2021 - YTD*2025)

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us